(Q44451311)

3 December 2017

Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients (English)

1 reference

3 December 2017

Birgül Vanizor Kural

1

1 reference

3 December 2017

Asim Orem

2

1 reference

3 December 2017

Gülseren Cimşit

3

1 reference

3 December 2017

Hüseyin Avni Uydu

4

1 reference

3 December 2017

Yunus Emre Yandi

5

1 reference

3 December 2017

Ahmet Alver

6

1 reference

3 December 2017

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

332

1 reference

3 December 2017

1-2

1 reference

3 December 2017

23-30

1 reference

Statistical association between psoriasis and diabetes: Further results

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Serum uric acid levels in untreated and PUVA-treated patients with psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Serum lipid and apolipoprotein levels in patients with psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Stress, inflammation and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Homocysteine and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Homocysteine: cholesterol of the 90s?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

The importance of hyperhomocysteinemia as a risk factor for diseases: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Is oxidized low‐density lipoprotein present in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Homocysteine accelerates endothelial cell senescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Work Stress and Metabolic and Hemostatic Risk Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Assessment of disease progress in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Homocysteine and atherothrombosis--mechanisms for injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Homocysteine inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion via nuclear factor-kappaB dependent pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Psoriasis: comparison of immunological markers in patients with acute and remission phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Plasma fibronectin in patients affected by psoriasis: relation with the extension of skin involvement and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Plasma fibronectin in psoriatic arthritis subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900082-2

10.1016/S0009-8981(03)00082-2

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference